PL380846A1 - 5'-O-[(N-acylo)amidofosforano]- i 5'-O-[(N-acylo)amidotiofosforano]- i 5'-O-[(N-acylo)amidoditiofosforano]- i 5'-O-[(N-acylo)amidoselenofosforano]-nukleozydy oraz sposób ich wytwarzania - Google Patents

5'-O-[(N-acylo)amidofosforano]- i 5'-O-[(N-acylo)amidotiofosforano]- i 5'-O-[(N-acylo)amidoditiofosforano]- i 5'-O-[(N-acylo)amidoselenofosforano]-nukleozydy oraz sposób ich wytwarzania

Info

Publication number
PL380846A1
PL380846A1 PL380846A PL38084606A PL380846A1 PL 380846 A1 PL380846 A1 PL 380846A1 PL 380846 A PL380846 A PL 380846A PL 38084606 A PL38084606 A PL 38084606A PL 380846 A1 PL380846 A1 PL 380846A1
Authority
PL
Poland
Prior art keywords
acyl
amidoselenophosphate
amidodithiophosphate
amidothiophosphate
amidophosphate
Prior art date
Application number
PL380846A
Other languages
English (en)
Other versions
PL216525B1 (pl
Inventor
Wojciech J. Stec
Janina Baraniak
Renata Kaczmarek
Ewa Wasilewska
Dariusz Korczyński
Katarzyna Pięta
Original Assignee
Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk filed Critical Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk
Priority to PL380846A priority Critical patent/PL216525B1/pl
Priority to EP07834897A priority patent/EP2097430A1/en
Priority to US12/444,774 priority patent/US20100137576A1/en
Priority to PCT/PL2007/000069 priority patent/WO2008048128A1/en
Publication of PL380846A1 publication Critical patent/PL380846A1/pl
Publication of PL216525B1 publication Critical patent/PL216525B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
PL380846A 2006-10-17 2006-10-17 5'-O-[(N-acylo)amidoditiofosforano] nukleozydy oraz sposób wytwarzania 5'-O-[(N-acylo)amidofosforano]-,5'-O-[(N-acylo)amidotiofosforano]-, 5'-O-[(N-acylo)amidoditiofosforano]nukleozydów PL216525B1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL380846A PL216525B1 (pl) 2006-10-17 2006-10-17 5'-O-[(N-acylo)amidoditiofosforano] nukleozydy oraz sposób wytwarzania 5'-O-[(N-acylo)amidofosforano]-,5'-O-[(N-acylo)amidotiofosforano]-, 5'-O-[(N-acylo)amidoditiofosforano]nukleozydów
EP07834897A EP2097430A1 (en) 2006-10-17 2007-10-16 5'-o-[(n-acyl)amidophosphate]- and 5'-o-[(n-acyl)amidothiophosphate]- and 5'-o-[(n-acyl)amidodithiophosphate]- and 5'-o-[n- acyl)amidoselenophosphate-derivatives of nucleosides and processes for the manufacture thereof
US12/444,774 US20100137576A1 (en) 2006-10-17 2007-10-16 5' o [(n acyl)amidophosphate] and 5' o [(n acyl)amidothiophosphate] and 5' o [(n acyl)amidodithiophosphate] and 5' o [(n acyl)amidoselenophosphate] derivatives of nucleosides and processes for the manufacture thereof
PCT/PL2007/000069 WO2008048128A1 (en) 2006-10-17 2007-10-16 5'-o-[(n-acyl)amidophosphate]- and 5'-o-[(n-acyl)amidothiophosphate]- and 5'-o-[(n-acyl)amidodithiophosphate]- and 5'-o-[(n- acyl)amidoselenophosphate]-derivatives of nucleosides and processes for the manufacture thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL380846A PL216525B1 (pl) 2006-10-17 2006-10-17 5'-O-[(N-acylo)amidoditiofosforano] nukleozydy oraz sposób wytwarzania 5'-O-[(N-acylo)amidofosforano]-,5'-O-[(N-acylo)amidotiofosforano]-, 5'-O-[(N-acylo)amidoditiofosforano]nukleozydów

Publications (2)

Publication Number Publication Date
PL380846A1 true PL380846A1 (pl) 2008-04-28
PL216525B1 PL216525B1 (pl) 2014-04-30

Family

ID=39016029

Family Applications (1)

Application Number Title Priority Date Filing Date
PL380846A PL216525B1 (pl) 2006-10-17 2006-10-17 5'-O-[(N-acylo)amidoditiofosforano] nukleozydy oraz sposób wytwarzania 5'-O-[(N-acylo)amidofosforano]-,5'-O-[(N-acylo)amidotiofosforano]-, 5'-O-[(N-acylo)amidoditiofosforano]nukleozydów

Country Status (4)

Country Link
US (1) US20100137576A1 (pl)
EP (1) EP2097430A1 (pl)
PL (1) PL216525B1 (pl)
WO (1) WO2008048128A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
KR20100102107A (ko) * 2007-11-06 2010-09-20 파마이센시아 코퍼레이션 β-뉴클레오시드의 새로운 합성 방법
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
AU2009329872B2 (en) 2008-12-23 2016-07-07 Gilead Pharmasset Llc Synthesis of purine nucleosides
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
SG184324A1 (en) 2010-03-31 2012-11-29 Gilead Pharmasset Llc Nucleoside phosphoramidates
NZ607996A (en) 2010-09-22 2014-07-25 Alios Biopharma Inc Substituted nucleotide analogs
CA2818853A1 (en) 2010-11-30 2012-06-07 Gilead Pharmasset Llc 2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus
EP2709613B2 (en) 2011-09-16 2020-08-12 Gilead Pharmasset LLC Methods for treating hcv
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
HK1206362A1 (zh) 2012-03-21 2016-01-08 Alios Biopharma, Inc. 硫代氨基磷酸酯核苷酸前藥的固體形式
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
WO2014047117A1 (en) * 2012-09-18 2014-03-27 Bristol-Myers Squibb Company Process for preparing phosphoramidate derivatives of nucleoside compounds for treatment of viral infections
EP2950786B1 (en) 2013-01-31 2019-11-27 Gilead Pharmasset LLC Combination formulation of two antiviral compounds
PT3038601T (pt) 2013-08-27 2020-06-30 Gilead Pharmasset Llc Formulação combinada de dois compostos antivirais
NZ729118A (en) 2014-08-25 2022-02-25 Medivir Ab Dioxolane analogues of uridine for the treatment of cancer
CA3182565A1 (en) 2015-03-06 2016-09-15 Atea Pharmaceuticals, Inc. .beta.-d-2'-deoxy-2'-.alpha.-fluoro-2'-.beta.-c-substituted-2-modified-n6-substituted purine nucleotides for hcv treatment
WO2018048937A1 (en) 2016-09-07 2018-03-15 Atea Pharmaceuticals, Inc. 2'-substituted-n6-substituted purine nucleotides for rna virus treatment
IL288737B (en) 2017-02-01 2022-09-01 Atea Pharmaceuticals Inc Hemisulfate nucleotide salt for treatment of hepatitis c virus
EP3773753A4 (en) 2018-04-10 2021-12-22 ATEA Pharmaceuticals, Inc. TREATMENT OF PATIENTS INFECTED WITH THE HEPATITIS C VIRUS WITH CIRRHOSIS
US10874687B1 (en) 2020-02-27 2020-12-29 Atea Pharmaceuticals, Inc. Highly active compounds against COVID-19
IL308921A (en) 2021-06-17 2024-01-01 Atea Pharmaceuticals Inc Combination anti-HCV therapy is beneficial

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359052A (en) * 1991-08-05 1994-10-25 Polish Academy Of Sciences Chalcophospholanes useful in the synthesis of oligonucleoside phosphorothioates, phosphorodithioates and related selenates
US5856465A (en) * 1996-05-24 1999-01-05 Polska Akademia Nauk Centrum Badan Molekularnych I Makromolekularnych Compositions and methods for the synthesis of chirally pure organophosphorus nucleoside derivatives
PL184612B1 (pl) * 1997-04-25 2002-11-29 Pan Sposób wytwarzania modyfikowanych P chiralnych analogów nukleotydów
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
CN101023094B (zh) * 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
WO2012040126A1 (en) * 2010-09-22 2012-03-29 Alios Biopharma, Inc. Substituted nucleotide analogs

Also Published As

Publication number Publication date
WO2008048128A1 (en) 2008-04-24
EP2097430A1 (en) 2009-09-09
PL216525B1 (pl) 2014-04-30
US20100137576A1 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
PL380846A1 (pl) 5'-O-[(N-acylo)amidofosforano]- i 5'-O-[(N-acylo)amidotiofosforano]- i 5'-O-[(N-acylo)amidoditiofosforano]- i 5'-O-[(N-acylo)amidoselenofosforano]-nukleozydy oraz sposób ich wytwarzania
IL191079A0 (en) Self-propellable endoscopic apparatus and method
GB2427214B (en) Adjustable length modular connector and method
EP2038876A4 (en) TELEPHONE-BASED TRADING SYSTEM AND METHOD
EP2051615A4 (en) SYSTEM AND METHOD FOR IN VIVO IMAGING
EP1959836A4 (en) SYSTEM AND METHOD FOR ULTRASONIC MEASUREMENT
GB0519316D0 (en) "Method and apparatus"
EP1958428A4 (en) SERVICE MANAGEMENT AND PRODUCTION MANAGEMENT SYSTEM AND METHOD
EP1850736A4 (en) SYSTEM, METHOD AND APPARATUS FOR NON-INVASIVE TARGETING
IL192759A0 (en) New method and system
EP2069901A4 (en) METHOD AND SYSTEM FOR SELECTION
GB0518998D0 (en) "Measurement apparatus and method"
GB2422501B (en) System And Method For Modular Display
EP1869909A4 (en) DETERMINATION METHOD AND SYSTEM
GB2447185B (en) Display system and method
GB0623500D0 (en) Wear indication apparatus and method
EP1949690A4 (en) INSPECTION SYSTEM AND METHOD
EP2052668A4 (en) ENDOSCOPE AND ENDOSCOPE INSPECTION METHOD
EP1781386A4 (en) GAME SHOW SYSTEM AND METHOD FOR ITS IMPLEMENTATION
IL159383A0 (en) Laryngoscope with time indicating means and method for use thereof
EP1928371A4 (en) ORTHOPEDIC PLASTER SYSTEM AND METHOD
GB0608016D0 (en) Imaging System And Method
GB0520900D0 (en) Method and system
AU2003288699A8 (en) Method for in vivo sensing
GB0608026D0 (en) Imaging System And Method